GlassScriptPhysician profile
David Peyok
NPI 1639530769
$4,724.75
in general payments reported to CMS, 2019-2025
16 companies · $1,743 in 2025
The $1,743 reported for 2025 was more than what 84% of Addiction Medicine (Psychiatry & Neurology) providers received nationally (typical 2025 total: $152).
See the full distribution for Addiction Medicine (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $687 · 2023: $883 · 2024: $1,412 · 2025: $1,743.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,853 · Education: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,852.75 |
| Education | $185.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $2,304.73 | 2022-2025 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $504.25 | 2022-2025 | Uzedy, Austedo Xr, Austedo Xr |
| Janssen Pharmaceuticals, INC | $373.59 | 2022-2025 | Invega Sustenna, Spravato, Invega Trinza |
| Neurocrine Biosciences, INC. | $333.10 | 2024-2025 | Ingrezza |
| Vanda Pharmaceuticals INC. | $266.10 | 2024-2025 | Fanapt |
| E.R. Squibb & Sons, L.L.C. | $238.43 | 2024-2025 | Cobenfy |
| Otsuka America Pharmaceutical, INC. | $202.00 | 2023-2025 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Alkermes, INC. | $153.58 | 2024-2025 | Aristada, Lybalvi, Aristada Initio |
| Abbvie INC. | $92.50 | 2023-2025 | |
| Lilly USA, LLC | $56.04 | 2022-2023 | Mounjaro, Trulicity |
| Mylan Specialty L.P. | $54.10 | 2022-2023 | Yupelri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $52.69 | 2022 | |
| Indivior INC. | $46.74 | 2023-2024 | Perseris |
| Treace Medical Concepts, INC. | $20.58 | 2024 | |
| Abiomed | $20.48 | 2024 | Impella |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $5.84 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Peyok listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.